ESG Inc. financial data

Symbol
ESGH on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
523 School House Rd, Kennett Square, PA
State of incorporation
NV
Fiscal year end
December 31
Former names
PLASMA INNOVATIVE INC. (to 11/13/2023)
Latest financial report
10-K - Q4 2024 - Apr 15, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 31.4 % +38.1%
Quick Ratio 14.4 %
Debt-to-equity 161 % +18.7%
Return On Equity 7.62 %
Return On Assets 3.46 %
Operating Margin 7.88 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 25.9M shares 0%
Common Stock, Shares, Outstanding 25.9M shares 0%
Entity Public Float 35.1M USD
Common Stock, Value, Issued 25.9K USD 0%
Weighted Average Number of Shares Outstanding, Basic 25.9M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 25.9M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 21.4M USD +187%
Cost of Revenue 9.13M USD +60.3%
Research and Development Expense 709K USD +16.2%
General and Administrative Expense 1.18M USD +33.4%
Operating Income (Loss) 1.69M USD
Nonoperating Income (Expense) -245K USD -101%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.25M USD
Net Income (Loss) Attributable to Parent 945K USD
Earnings Per Share, Basic 0.04 USD/shares
Earnings Per Share, Diluted 0.04 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 167K USD -51.3%
Inventory, Net 2.91M USD +76%
Assets, Current 6.97M USD +211%
Property, Plant and Equipment, Net 769 USD -25.3%
Assets 29.8M USD +13.4%
Accounts Payable, Current 4.6M USD +254%
Liabilities, Current 13.8M USD +29.4%
Liabilities 16M USD +19.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -711K USD -65.3%
Retained Earnings (Accumulated Deficit) -169K USD +84.9%
Stockholders' Equity Attributable to Parent 10.3M USD +6.89%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 13.8M USD +6.73%
Liabilities and Equity 29.8M USD +13.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 95K USD -80.9%
Net Cash Provided by (Used in) Financing Activities 138K USD
Common Stock, Shares Authorized 65M shares 0%
Common Stock, Shares, Issued 25.9M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 491K USD +37.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 167K USD -51.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 150K USD +5.58%
Deferred Tax Assets, Valuation Allowance 3.05M USD +20.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Depreciation 1.7M USD +22.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -747K USD -653%
Property, Plant and Equipment, Gross 24.9M USD -0.05%
Deferred Income Tax Expense (Benefit) -174K USD -35.2%
Deferred Tax Assets, Operating Loss Carryforwards 3.05M USD +20.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 11.2M USD 0%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 67.9K USD -1.45%
Depreciation, Depletion and Amortization 453K USD -3.87%
Interest Expense 125K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%